Table 1 Preoperative clinical characteristics in the high cancerous (HC) and high surrounding (HS) groups
From: Evaluation of fluorescence imaging with indocyanine green in hepatocellular carcinoma
HC group | HS group | P | |
|---|---|---|---|
n = 116 | n = 74 | ||
Sex (male/female) | 83/33 | 60/14 | 0.1377 |
Age (years) | 68.8 ± 9.3 | 69.6 ± 9.3 | 0.5603 |
HBV/HCV/NBC | 18/73/25 | 12/39/23 | 0.2953 |
Alcohol abuse (+) | 25 (22 %) | 14 (19 %) | 0.6613 |
Esophageal and/or gastric varices (+) | 23 (20 %) | 1 (1 %) | 0.0002 |
ICGR15 (%) | 18.8 ± 10.5 | 12.8 ± 7.6 | <0.0001 |
Days between injection of ICG and operation | 25.5 ± 14.0 | 24.7 ± 12.3 | 0.7147 |
Platelet count (×104/mL) | 14.2 ± 6.2 | 19.6 ± 9.6 | <0.0001 |
Total bilirubin (mg/dL) | 0.83 ± 0.33 | 0.69 ± 0.23 | 0.0016 |
Albumin (g/dL) | 3.7 ± 0.5 | 3.8 ± 0.5 | 0.5662 |
Prothrombin time (%) | 89 ± 13 | 91 ± 11 | 0.2973 |
AST (U/L) | 51 ± 27 | 37 ± 22 | 0.0002 |
ALT (U/L) | 49 ± 34 | 38 ± 33 | 0.0427 |
AFP (ng/mL) | 4103 ± 17,724 | 1829 ± 6357 | 0.3005 |
PIVKA-II (mAU/mL) | 3476 ± 11,448 | 2761 ± 9618 | 0.6657 |